View in EDS HTML Full Text PDF Full Text

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.

Saved in:
Bibliographic Details
Title: Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.
Authors: Boissière-Michot F; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France., Chateau MC; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France., Thézenas S; Biometry Department, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France., Lafont V; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France., Crapez E; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France., Sharma P; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France., Bobrie A; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.; Department of Medical Oncology, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France., Roger P; Pathology Department, Nîmes University Hospital, Nîmes, France., Guiu S; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.; Department of Medical Oncology, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France., Jacot W; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.; Department of Medical Oncology, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.; Faculty of Medicine, Montpellier University, Montpellier, France.
Source: Frontiers in immunology [Front Immunol] 2024 Dec 12; Vol. 15, pp. 1507371. Date of Electronic Publication: 2024 Dec 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39723208
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boissière-Michot+F%22">Boissière-Michot F</searchLink>; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Chateau+MC%22">Chateau MC</searchLink>; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Thézenas+S%22">Thézenas S</searchLink>; Biometry Department, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Lafont+V%22">Lafont V</searchLink>; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Crapez+E%22">Crapez E</searchLink>; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Bobrie+A%22">Bobrie A</searchLink>; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.; Department of Medical Oncology, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Roger+P%22">Roger P</searchLink>; Pathology Department, Nîmes University Hospital, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22Guiu+S%22">Guiu S</searchLink>; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.; Department of Medical Oncology, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Jacot+W%22">Jacot W</searchLink>; Translational Research Unit, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Montpellier, France.; Department of Medical Oncology, Montpellier Cancer Institute Val d'Aurelle, Montpellier, France.; Faculty of Medicine, Montpellier University, Montpellier, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Dec 12; Vol. 15, pp. 1507371. <i>Date of Electronic Publication: </i>2024 Dec 12 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39723208
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1507371
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1507371
    Titles:
      – TitleFull: Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boissière-Michot F
      – PersonEntity:
          Name:
            NameFull: Chateau MC
      – PersonEntity:
          Name:
            NameFull: Thézenas S
      – PersonEntity:
          Name:
            NameFull: Lafont V
      – PersonEntity:
          Name:
            NameFull: Crapez E
      – PersonEntity:
          Name:
            NameFull: Sharma P
      – PersonEntity:
          Name:
            NameFull: Bobrie A
      – PersonEntity:
          Name:
            NameFull: Roger P
      – PersonEntity:
          Name:
            NameFull: Guiu S
      – PersonEntity:
          Name:
            NameFull: Jacot W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 12
              Text: 2024 Dec 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1